Christopher Y. Park - Concepedia

Author

Christopher Y. Park

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Christopher Park, Christopher Y Park, Christopher Y. Park, Christopher Y. Park (236583), Christopher Y. Park, Cynthia E. Dunbar, Park, Christopher

208

Publications

15.5K

Citations

H-Index

123

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Stanford University Howard Hughes Medical Institute New York University Rockefeller University

About

Christopher Y. Park is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	42	10.2K
2	Health Sciences	13	14	4.1K
3	Engineering	4	4	668
4	Natural Sciences	2	2	240
5	Social Sciences	2	2	166

Christopher Y. Park

Publications

14.7K

Citations

H-Index

Page 1

	Year	Citations
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis Siddhartha Jaiswal, Catriona Jamieson, Wendy W. Pang, Cell Cd47 IsHematological MalignancyMedicineMalignant Blood DisorderImmunology	2009	1.5K
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma Mark P. Chao, Ash A. Alizadeh, Chad Tang, Cell Lymphoid NeoplasiaCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorEradicate Non-hodgkin Lymphoma	2010	1K
A majority of m<sup>6</sup>A residues are in the last exons, allowing the potential for 3′ UTR regulation Shengdong Ke, Endalkachew A. Alemu, Claudia Mertens, Genes & Development	2015	814
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 Mark P. Chao, Siddhartha Jaiswal, Rachel Weissman-Tsukamoto, Science Translational Medicine	2010	750
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression Luisa Cimmino, Igor Dolgalev, Yubao Wang, Cell Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaPathologyAdult T-cell Leukemia-lymphoma	2017	684
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression Omar Abdel‐Wahab, Mazhar Adli, Lindsay M. LaFave, Cancer Cell Hematological MalignancyChromatinSomatic VariantGeneticsGene Expression	2012	585
Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord Blood Ravindra Majeti, Christopher Y. Park, Irving L. Weissman Cell stem cell Developmental BiologyMultipotent Hematopoietic ProgenitorsGeneticsHematologyBlood Cell	2007	565
Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche Haobin Ye, Biniam Adane, Nabilah Khan, Cell stem cell MedicineStem Cell MobilizationBiological MicroenvironmentsMetabolic AdaptationAdipose Tissue Niche	2016	527
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms Eli L. Diamond, Benjamin H. Durham, Julien Haroche, Cancer Discovery	2015	518
Immune Response in Stat2 Knockout Mice Christopher Y. Park, Suzanne Li, Edward Cha, Immunity InflammationAutoimmune DiseaseImmune Cell DevelopmentImmunologyStat2 Knockout Mice	2000	403

Page 1